AWM
Avior Wealth Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-29
| Closed | -$5.35K | – | 1080 |
|
|
2024
Q4 | $5.35K | Buy |
+29
| New | +$5.35K | ﹤0.01% | 1835 |
|
|
2024
Q2 | – | Sell |
-483
| Closed | -$131K | – | 2591 |
|
|
2024
Q1 | $131K | Buy |
+483
| New | +$131K | 0.01% | 852 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1171 |
|
|
2022
Q2 | – | Sell |
-527
| Closed | -$149K | – | 1089 |
|
|
2022
Q1 | $149K | Hold |
527
| – | – | 0.01% | 464 |
|
|
2021
Q4 | $198K | Hold |
527
| – | – | 0.02% | 431 |
|
|
2021
Q3 | $217K | Sell |
527
-25
| -5% | -$10.3K | 0.02% | 411 |
|
|
2021
Q2 | $204K | Sell |
552
-3,375
| -86% | -$1.25M | 0.02% | 400 |
|
|
2021
Q1 | $1.14M | Sell |
3,927
-473
| -11% | -$137K | 0.12% | 158 |
|
|
2020
Q4 | $1.1M | Buy |
4,400
+368
| +9% | +$91.8K | 0.14% | 141 |
|
|
2020
Q3 | $913K | Sell |
4,032
-260
| -6% | -$58.9K | 0.13% | 147 |
|
|
2020
Q2 | $748K | Buy |
4,292
+2,022
| +89% | +$352K | 0.12% | 163 |
|
|
2020
Q1 | $286K | Hold |
2,270
| – | – | 0.06% | 280 |
|
|
2019
Q4 | $346K | Hold |
2,270
| – | – | 0.06% | 294 |
|
|
2019
Q3 | $300K | Buy |
2,270
+410
| +22% | +$54.2K | 0.05% | 300 |
|
|
2019
Q2 | $264K | Sell |
1,860
-350
| -16% | -$49.7K | 0.05% | 319 |
|
|
2019
Q1 | $321K | Buy |
2,210
+720
| +48% | +$105K | 0.07% | 264 |
|
|
2018
Q4 | $168K | Buy |
+1,490
| New | +$168K | 0.04% | 345 |
|